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During the past years there has been a significant increase in the number of patients treated for abdominal aortic aneurysms (AAA). This is attributed to the increase in diagnostic modalities, such as Doppler ultrasound and computed tomography, as well as availability of new treatment options (1, 2, 3) . One of the greatest breakthroughs in vascular surgery was probably in the early nineties of the past century with the introduction of a minimally invasive method of AAA exclusion by means of a stentgraft introduced by Parodi (4) and Volodos (5) . This new method enabled surgeons to 5 Influence of suprarenal stentgraft fixation on renal function in patients after abdominal aortic aneurysm endovascular exclusion treat patients previously disqualified from traditional aneurysmectomy (6, 7) . Nowadays, there are several commercially available stent-grafts with slight differences in their construction. Some have an uncovered proximal stent, which is used to fixate the graft in the aorta above the renal arteries (NN) ( fig. 1 ), while others, with infrarenal fixation, are constructed with only covered segments (PN) ( fig. 2) .
In both cases, inclusion criteria are determined by the morphological parameters of the aneurysm and the proximal neck (the section of the aorta below the renal arteries). The aneurysmal neck is considered to be the key fixation point which later determines the success rate in AAA exclusion. Lack of proper stentgraft adherence at this point may lead towards a proximal type I endoleak, resulting in an increase in aneurysm diameter with possibility of its rupture (8, 9) . It is currently established that the proximal neck should be cylindrical in shape and have at least 15 mm in length. These parameters are the optimal minimum for the use of a system with infrarenal fixation (PN). In cases where these criteria are not fulfilled (aneurysmal neck length<15 mm or a conical neck shape) the system with suprarenal fixa- Fig. 1 . Suprarenal stentgraft fixation -Zenith ® (Cook) stentgraft tion should be considered. This enables better fixation and prevents migration of the stentgraft into the aneurysmal sac. Fixation is achieved by a special wire scaffold, which is suspended across the orfices of the renal arteries (11, 12, 13) . Some concern is given to the fact that the stent expanded across the orfices of the renal arteries may lead towards impaired blood flow to the kidneys resulting in renal infarcts or an increased creatinine level (14, 15) .
The aim of the study was to assess the results of suprarenal stentgraft fixation on renal functioning in patients undergoing endovascular abdominal aortic aneurysm repair. gnostics included spiral computed tomography with 3D reconstruction for the assessment of AAA and iliac arterial morphology.
MATERIAL AND METHODS

During
The authors assumed that a proximal neck <15 mm was an indication to use the stentgraft system with suprarenal fixation. Surgery was preformed in the operating theatre with the use of a mobile digital substraction angiography C-arm (OEC 9600).
Prospective analysis considered 139 consecutive patients with AAA who underwent elective stentgraft implantation between January 2003 and December 2004. The study group comprised 130 male and 9 female patients. Patient age ranged between 45 and 90 years (mean: 70.3 years).
The inclusion criteria for the prospective trial comprised a documented normal preoperative renal function defined by a creatinine level = 1.5 mg/dL and a minimum follow-up period of 3 months after surgery. These inclusion criteria were fulfilled by 118 patients who were consequently divided into two groups: the suprarenal (NN) or infrarenal (PN) -based on the stentgraft system used ( fig. 1 and 2 ). The suprarenal group consisted of 66 patients (mean age: 70.8±6.7 years), while the infrarenal group consisted of 52 patients (mean age: 70±7.64 years). Both groups were compared on the basis of co-morbidities, operative risk (ASA score) and volume of contrast medium used intraoperatively (Iomeron 300, AstraTech). There were no significant differences considering these parameters (p<0.05) (tab. 1 and fig. 3 ). The follow-up period and the number of performed follow-up CT scans was also comparable.
Types of stentgrafts used were presented in tab. 2.
In this study creatinine (cr) and creatinine clearance (Cl. cr) levels were assessed in both groups, before surgery, between the 3 rd and 7 th postoperative day and 3 months after stentgraft implantation. Thus, renal functioning was evaluated. The Cockraft-Glaut equation was used to calculate creatinine clearance levels:
Cl.cr = (140 age) x body weight cr x 72 (x 0,85 for females)
The results were statistically analyzed using the chi-square and t-Student tests. Differences were considered significant at p<0.05. Calculations and graphical analysis were performed using the STATISTICA software program for Windows (StatSoft, Inc 2004; version 6).
RESULTS
Considering all patients intraoperative angiography performed directly after stent-graft implantation showed complete patency of both renal arteries and of the implanted graft. This was further confirmed during scheduled followup CT scans, which demonstrated no kidney malperfusion ( fig. 4 and 5) .
During the follow-up period (between the 3 rd and 7 th day and 3 months after surgery) in both groups no renal insufficiency was observed requiring dialysis. In 59/66 (89.4%) patients from the suprarenal group, and 47/52 (90.4%) infrarenal group patients normal creatinine values (<1.5 mg/dL) were observed during the first week after surgery. At the same time, in 7 (10.6%) suprarenal group, and 5 (9.6%) infrarenal group patients, an increase in creatinine levels >1.5 mg/dL was observed, although the difference between both groups was statistically insignificant (p=0.83). After three months an elevated creatinine level >1.5 mg/dL was observed in only 2 suprarenal one infrarenal group patients (3% and 2%, respectively; p =0.34).
Mean creatinine values in both groups were also compared without significant increase during the postoperative period, as well as statistically significant differences between suprarenal and infrarenal groups. Table 3 and fig. 6 presented the above-mentioned data.
Creatinine clearance values (Cl. cr) during each time interval were also assessed in correlation to the type of stentgraft used. Statistical analysis showed no significant differences in Cl.cr between both groups during the first week Fig. 3 . Amount of contrast medium used (ml) Influence of suprarenal stentgraft fixation on renal function in patients after abdominal aortic aneurysm endovascular exclusion (between the 3 rd and 7 th day), as well as third postoperative month. Also, no negative effects from the endovascular procedure itself were observed in relation to the creatinine clearance. The above-mentioned were presented in tab. 3 and fig. 7 .
DISCUSSION
Renal insufficiency is one of the main reasons behind postoperative mortality after traditional aneurysmectomy. This is particularly obvious in patients with high operative risk and 8 Z. Gałązka et al. serious cardiovascular co-morbidities (16, 17) . Thus, endovascular methods of AAA repair by means of stentgraft implantation have become increasingly popular. Thanks to the introduction of this method, the amount of intraoperative trauma has been decreased by avoiding laparotomy, compression of the mesenterium, preparation of the aneurysm and crossclamping of the aorta. This decreases the amount of catecholamines, cortyzol and cytokins released, which in turn limits the risk of organ reperfusion injury (18) (19) (20) (21) .
An important contraindication for endovascular surgery is the morphology of the aneurysmal neck and especially its length. LawrenceBrown and associates from Australia constructed an endovascular stentgraft, which included a suprarenal fixation segment, which was later on modified to include hooks and barbs (22) .
The stentgraft described in this study was used in cases where the aneurysmal neck was <15 mm, which is in accordance with other authors' opinions (12, 23, 24) . The suprarenal sys- tem prevents graft migration and at the same time decreases the probability of type I endoleaks, which may lead towards aneurysmal rupture.
On the other hand, some authors pointed out that the implantation of a stent-graft impaired the patients' renal function in 6 to 10% of cases, independently of the type of graft (25) (26) (27) (28) 35) .
These results are analogous to our results, where the percentage of patients with a creatinine level >1.5 mg/dL during the first week was as follows: suprarenal group -10.6% and infrarenal group -9.6%. This may be explained by the use of iodinated contrast medium during intraoperative angiography (29) . Therefore, other safer contrasts such as gadolinium and carbon dioxide are currently beginning to be used for vessel visualization.
In 2000, a study was published in which Nacetylocystein was used prior to surgery which significantly reduced the nephrotoxic effects of the iodinated contrast medium (31).
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Renal infarctions occurring after non-intentional coverage of the renal artery ostia by the graft material were also observed (15) . Renal infarctions caused by transposition of thrombotic material from the aortic wall occurring as a result of guide-wire manipulation were also described (32) .
Some authors suggest that the impairment of renal function may depend mostly on the presence of suprarenal fixation. Although, the uncovered part of the proximal segment crossing the renal ostia causes turbulent blood flow, which may exert a thrombogenic effect in this area (33, 34) .
Experimental studies have proven that enhancing the endograft construction with extra hooks and barbs increases thrombocyte activation, thrombus formation and stimulates neointimal growth (14) .
Considering the above-mentioned doubts, the current opinion is that the increase in serum creatinine levels observed in some cases after endografting is mostly transient and does not impair renal function during long-term follow-up (23, 26, 35, 36) . Similar results were observed in this study, where the number of patients with an elevated creatinine level >1.5 mg/dL decreased from 10.6% and 9.6% in the first week to 3% and 2% after 3 months from stentgraft implantation. CONCLUSIONS 1. In case of patients after endovascular exclusion of abdominal aortic aneurysms, the implantation of a stentgraft with suprerenal fixation is a safe method, which does not cause significant renal functioning impairment during the postoperative period. 2. The use of the suprarenal fixation system enables successful AAA elimination, including aneurysms with a short proximal neck (length <15 mm). This in turn increases the number of patients eligible for AAA treatment by means of stentgraft implantation.
